Radiation therapy: A major factor in the five-year survival analysis of women with breast cancer in Lagos, Nigeria

Makanjuola, Samira; Popoola, Abiodun; Oludara, Mobolaji

doi:10.1016/j.radonc.2014.03.013

Cited by 29 publications

(36 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Five-year survival rates from breast cancer in low and middle income countries (LMICs) are estimated at 57% [20]. In SSA countries, breast cancer survival estimates are available for Ethiopia, The Gambia, Nigeria, South Africa and Uganda [4–6;21–23], and for young patients (<35 years) from Senegal [24]. Comparisons with these studies are hindered by methodological differences and limitations of the individual studies.…”

Section: 0 Discussionmentioning

confidence: 99%

Breast cancer survival in Soweto, Johannesburg, South Africa: A receptor-defined cohort of women diagnosed from 2009 to 11

Cubasch

Dickens

Joffe

et al. 2018

Cancer Epidemiology

View full text Add to dashboard Cite

In this South African cohort, breast cancer survival is suboptimal, but was better for early stage and hormone receptor-positive tumours. Efforts to reduce clinic losses in the immediate post-diagnosis period, in addition to early presentation and accelerated diagnosis and treatment, are needed to prevent breast cancer deaths, and survival improvements need to be monitored using prospective studies with active follow-up.

show abstract

Section: 0 Discussionmentioning

confidence: 99%

Breast cancer survival in Soweto, Johannesburg, South Africa: A receptor-defined cohort of women diagnosed from 2009 to 11

Cubasch

Dickens

Joffe

et al. 2018

Cancer Epidemiology

View full text Add to dashboard Cite

show abstract

“…In the sub‐Saharan African region, where 75% of HIV‐positive breast cancer patients live, breast cancer survival rates are generally some of the lowest worldwide. For HIV‐positive and HIV‐negative women combined, 5‐year breast cancer survival estimates are 24% in Nigeria, 46% in Ethiopia and 64/80% in black/white South Africans, which compare to over 85% in the US . Moreover, HIV‐positive breast cancer patients have lower survival than their setting‐matched HIV‐negative counterparts.…”

Section: Discussionmentioning

confidence: 99%

Breast cancer in women living with HIV: A first global estimate

McCormack

Febvey-Combes

Ginsburg

et al. 2018

Intl Journal of Cancer

View full text Add to dashboard Cite

There is a growing population of older women living with HIV/AIDS (WLWHA). Breast cancer is a common cancer in women worldwide, but the global number of breast cancers in WLWHA is not known. We estimated, for each UN sub-region, the number and age distribution of WLWHA who were diagnosed with breast cancer in 2012, by combining IARC-GLOBOCAN estimates of age-country specific breast cancer incidence with corresponding UNAIDS HIV prevalence. Primary analyses assumed no HIV-breast cancer association, and a breast cancer risk reduction scenario was also considered. Among 16.0 million WLWHA aged 15+ years, an estimated 6,325 WLWHA were diagnosed with breast cancer in 2012, 74% of whom were in sub-Saharan Africa, equally distributed between Eastern, Southern and Western Africa. In most areas, 70% of HIV-positive breast cancers were diagnosed under age 50. Among all breast cancers (regardless of HIV status), HIV-positive women constituted less than 1% of the clinical burden, except in Eastern, Western and Middle Africa where they comprised 4-6% of under age 50 year old breast cancer patients, and in Southern Africa where this patient subgroup constituted 26 and 8% of breast cancers diagnosed under and over age 50 respectively. If a deficit of breast cancer occurs in WLWHA, the global estimate would reduce to 3,600. In conclusion, worldwide, the number of HIV-positive women diagnosed with breast cancer was already substantial in 2012 and with an expected increase within the next decade, early detection and treatment research targeted to this population are needed.

show abstract

“…Some of such areas are: CT images, growth factor levels in incident breast cancer, hormone receptor status, cytokine circulation, secretagogue users in breast cancer treatments, chemokine levels, breast cancer and diabetes mellitus co-infection and treatment, breast cancer and HIV treatment, breast cancer and pregnancy. Others are: proteome analysis, risk factors analysis, breast examination, screening, management and breast cancer awareness, epidemiology, risk assessment tools, treatment options: radiotherapy treatment versus chemotherapy, survival analysis, breast cancer subtypes, biomarkers, socio-cultural barriers to treatment, socio-demographic factors and alternative medicine approach, genetic risk, dietary patterns, early diagnostics and treatment and others [1] , [2] , [3] , [4] , [5] , [6] , [7] , [8] , [9] , [10] , [11] , [12] , [13] , [14] , [15] , [16] , [17] , [18] , [19] , [20] , [21] , [22] , [23] , [24] , [25] , [26] .…”

Section: Experimental Design Materials and Methodsmentioning

confidence: 99%

Breast cancer patients in Nigeria: Data exploration approach

2017

View full text Add to dashboard Cite

Breast cancer is the type of cancer that develops from breast tissue; it is mostly common in women and it is one of the most studied diseases, largely because of its high mortality (second to lung cancer). However, it occurs in males also. This article presents a statistical study of the distribution of age, gender, length of stay, mode of diagnosis, status (dead or alive) after treatment and the location of breast cancer among 300 patients admitted in the University of Ilorin teaching hospital, Ilorin, Nigeria. The study covers a period of five (5) years; from 2011 to 2016 and logistic regression was used to perform the basic analysis in this study. It was discovered that the age of patients and the location of the breast cancer (right or left) contributes significantly to the survival of the patients. However, early detection and treatment of the disease is highly encouraged. This study also recommends that awareness should be taken to the grassroots and males should not be excluded from this discussion.

show abstract

Radiation therapy: A major factor in the five-year survival analysis of women with breast cancer in Lagos, Nigeria

Cited by 29 publications

References 14 publications

Breast cancer survival in Soweto, Johannesburg, South Africa: A receptor-defined cohort of women diagnosed from 2009 to 11

Breast cancer survival in Soweto, Johannesburg, South Africa: A receptor-defined cohort of women diagnosed from 2009 to 11

Breast cancer in women living with HIV: A first global estimate

Breast cancer patients in Nigeria: Data exploration approach

Contact Info

Product

Resources

About